SEARCH

Current Edition

breast cancer

Lilly drug cleared by FDA for wider use in breast cancer

The new label opens up a significant market opportunity for Lilly, as about 70% of people diagnosed with breast cancer have the hormone receptor positive, …

Continue Reading →